BLR&D Research Career Scientist Award Application
BLR
基本信息
- 批准号:9899091
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAlveolar MacrophagesAmericanAnimalsAreaAutoimmune DiseasesAwardBiological SciencesBrain InjuriesCause of DeathCell DeathCell Differentiation processCellsCessation of lifeChronicCollaborationsCommunicationDevelopmentDiseaseDoctor of MedicineDoctor of PhilosophyFacultyFailureFunctional disorderFundingGoalsGovernmentGrant ReviewHealthHealthcareHealthcare SystemsHemorrhageHemorrhagic ShockHepatologyImmunologyInfectionInflammasomeInflammationInstitutionInterleukin-1InternationalInterventionJournalsLaboratoriesLiteratureMediatingMedicalMedicineMentorsMolecularNatural ImmunityNatureOperative Surgical ProceduresOrganPathogenesisPatientsPeer ReviewPeptidesPermeabilityPhasePhysiciansPlayPopulationPostdoctoral FellowPreventive InterventionPrincipal InvestigatorPublicationsResearchResearch PersonnelResearch Project GrantsReview CommitteeRoleScienceScientistSepsisSignal PathwaySignal TransductionSpinal InjuriesStrokeStudy SectionSystemic Inflammatory Response SyndromeTherapeutic InterventionTimeToll-like receptorsTraumaTrauma patientUnited States National Institutes of HealthUniversitiesVeteransWorkbasecareerclinical investigationcytokineeditorialhuman diseaseimprovedinstitutional biosafety committeemembermortalitymultidisciplinarynew therapeutic targetnovelpatient populationpeerpost-traumapreventprogramsprophylacticprotein complexsenior facultysurgical researchsurvival outcomesymposiumtherapy developmentvisiting scholar
项目摘要
PROJECT SUMMARY
Jie Fan, M.D., M.Sc. has been working in the VA Pittsburgh Healthcare System (VAPHS) since
2003, and is a Director of the Multidisciplinary Surgical Research Program, a Vice Chair of the
Institutional Biosafety Committee in VAPHS, and a tenured Full Professor of the Department of Surgery
at the University of Pittsburgh. He is a Principal Investigator working on the cellular and molecular
mechanisms of sepsis, post-trauma systemic inflammatory response syndrome (SIRS) and acute lung
injury (ALI), an important but exceptionally difficult area. His laboratory has been funded by two VA
merit review grants and four NIH research grants (R01, P50, and R56).
The burden of trauma-related diseases is considerable. Following exsanguination and/or brain
injury that commonly result in early phase death, more than 60% of surviving patients later die of
causes related to the development of SIRS, sepsis, and ALI. This patient population is well suited for
prophylactic interventions aimed at preventing these occurrences because of the time lag before the
onset of organ inflammation and failure. Nonetheless, few specific targets have been identified that
predispose to SIRS and ALI. The long term goal of Dr. Fan’s studies is to provide a new understanding
of the mechanisms of post-trauma inflammation and organ dysfunction, and therefore, to potentially
provide novel targets for preventive and therapeutic interventions in post-trauma SIRS, sepsis, and ALI.
The studies by Dr. Fan’s team will also provide a greater understanding of the pathogenesis of multiple
human diseases in which inflammation plays a central role.
ALI is one of the common endpoints of SIRS and sepsis. SIRS and sepsis are common causes of
mortality following surgery, infection, spinal injury, stroke, hemorrhage, and trauma in the veteran
population. And thus, Dr. Fan’s research is highly relevant to Veterans’ health.
Dr. Fan’s research provides critical information that can be used toward the development of
therapies for veterans with post-trauma inflammation and ALI. He is a highly productive Principal
Investigator with a long track record of both VA and NIH funding. He has also served in roles such as
Co-Investigator, Consultant, and Collaborator on numerous other research grants. His research and
collaborations have resulted in 113 peer-reviewed publications, many of them in the best scientific
journals and with high impact factors, including Nature Medicine, Nature Communications, Journal of
Clinical Investigation, Hepatology, Journal of Hepatology, Cell Death & Differentiation, and Journal of
Immunology. Dr. Fan’s work is renowned by his peers nationally and internationally. He has been an
invited speaker at numerous national and international conferences and at many research and
educational institutions. He serves as a reviewer in a number of national peer-review committees,
including VA, NIH, DoD, and American Institution of Biological Sciences study sections. He also serves
as editor-in-chief, member of editorial board, and invited reviewer for over 50 scientific journals. He has
mentored 27 VA and non-VA trainees including Ph.D. candidates, postdoctoral fellows, residents, junior
surgery faculties, and visiting scholars, many of whom have now become independent scientists or
physician scientists. Dr. Fan is a 2010 recipient of the Excellence in Government Award for Outstanding
Contribution to Medical Sciences.
项目摘要
Jie Fan,M.D.,M.Sc。由于
2003年,是多学科外科研究计划的主任,是该计划的副主席
VAPAS的机构生物安全委员会,以及终身的手术教授
在匹兹堡大学。他是在细胞和分子上工作的主要研究员
败血症,创伤后全身炎症综合征(SIRS)和急性肺的机制
受伤(ALI),这是一个重要但非常困难的领域。他的实验室由两个VA资助
绩效审查赠款和四项NIH研究补助金(R01,P50和R56)。
与创伤相关疾病的燃烧相当大。遵循解血和/或大脑
通常导致早期死亡的伤害,超过60%的尚存患者后来死亡
与Sir,败血症和Ali的发展有关的原因。这个患者群体非常适合
预防性干预措施旨在防止这种情况,因为
器官炎症和失败的发作。但是,很少有人确定
尊敬的先生和阿里。范博士研究的长期目标是提供新的理解
创伤后感染和器官功能障碍的机制,因此
提供新的靶标,用于在创伤后SIRS,败血症和Ali中进行预防和治疗性干预措施。
范博士团队的研究还将对多重发病机理有更深入的了解
炎症起着核心作用的人类疾病。
阿里是爵士和败血症的常见终点之一。先生和败血症是
老兵手术,感染,脊柱损伤,中风,出血和创伤后的死亡率
人口。因此,范博士的研究与退伍军人的健康高度相关。
Fan博士的研究提供了可用于开发的关键信息
感染后感染和阿里的退伍军人的治疗。他是高产校长
VA和NIH资金的长期记录的调查员。他还曾担任过
其他众多研究赠款的共同投资者,顾问和合作者。他的研究和
合作导致了113个同行评审的出版物,其中许多是最佳科学的出版物
期刊和高影响因素,包括自然医学,自然传播,杂志
临床研究,肝病学,肝病学杂志,细胞死亡与分化和杂志
免疫学。范博士的作品在国内和国际上以他的同龄人而闻名。他一直是
邀请了许多国家和国际会议以及许多研究的发言人
教育机构。他在许多国家同行评审委员会中担任审稿人,
包括VA,NIH,DOD和美国生物科学学院研究部分。他也服务
作为主编,编辑委员会成员,并邀请了50多个科学期刊的审稿人。他有
指导了27名VA和非VA学员,包括博士学位。候选人,博士后研究员,居民,初中
外科学院和访问学者,其中许多人现在已成为独立科学家或
医师科学家。 Fan博士是2010年获得政府卓越奖的获得者
对医学科学的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jie Fan其他文献
Jie Fan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jie Fan', 18)}}的其他基金
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
10618774 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
9885001 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
10293529 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
- 批准号:
10260392 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
- 批准号:
9593050 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Aging-Related Mechanism of Post-Hemorrhagic Shock Acute Lung Injury
失血性休克后急性肺损伤的衰老相关机制
- 批准号:
9130376 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Cell Death Mechanism of Acute Lung Injury in Sepsis
脓毒症急性肺损伤的细胞死亡机制
- 批准号:
9275434 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似国自然基金
新冠病毒N蛋白通过结合RAGE以促进肺泡巨噬细胞内质网-线粒体接触位点(MAM)的形成而诱导急性肺损伤的机制研究
- 批准号:82370080
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
- 批准号:82360024
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
SIRT5-线粒体代谢轴失调介导SORT1Hi肺泡巨噬细胞METs形成在围术期急性肺损伤中的作用及机制研究
- 批准号:82371292
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
HO-1修饰iPSC-MSCs来源外泌体调控肺泡巨噬细胞糖代谢重编程在脓毒症急性肺损伤中的作用及机制研究
- 批准号:82372154
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向HMGB1的WGA-siRNA纳米生物材料抑制肺泡巨噬细胞焦亡在烧伤脓毒症急性肺损伤的作用和分子机制
- 批准号:82372517
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
-- - 项目类别:
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
- 批准号:
10677924 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
- 批准号:
10725702 - 财政年份:2023
- 资助金额:
-- - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
-- - 项目类别: